| InvestSMART Group Limited (INV) ORDINARY FULLY PAID |
Financials |
$17 |
Address to Shareholders - Chairman and CEO
|
20 Nov 2025 8:19AM |
$0.120 |
$0.120 |
fallen by
0%
|
|
| Activeport Group Ltd (ATV) ORDINARY FULLY PAID |
Information Technology |
$22 |
ATV Accelerates NaaS Revenue
|
20 Nov 2025 8:19AM |
$0.028 |
$0.019 |
fallen by
32.14%
|
|
ATV - Price-sensitive ASX Announcement
Full Release
Key Points
- Activeport Group Ltd signs nine new channel partners in Australia.
- The company's Global Edge platform offers fast and flexible network provisioning for enterprise customers.
- Activeport is establishing itself as a challenger in Australia’s enterprise connectivity market.
- The Global Edge platform integrates features like cloud access and cybersecurity.
- Rapid adoption of Global Edge by channel partners is driving significant revenue growth.
- Access to FibreconX and the addition of NBN accelerates revenue growth.
- Integration to Activeport’s NNI gateway in Singapore enhances connections between Asia and Australia.
- Activeport's strategy is validated by the surge in channel partner sign-ups.
- Activeport's software overlay delivers automation and cloud-native integration.
- The company aims to be the go-to orchestration layer for next-gen enterprise networking in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kore Potash Plc (KP2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$285 |
Rule 8.3 of the Takeover Code
|
20 Nov 2025 8:18AM |
$0.062 |
$0.055 |
fallen by
11.29%
|
|
| Australian Agricultural Company Limited (AAC) ORDINARY FULLY PAID |
Consumer Staple |
$871 |
FY26 Half Year Results Presentation
|
20 Nov 2025 8:18AM |
$1.440 |
$1.445 |
risen by
0.35%
|
|
AAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating profit increased by $19.6 million to $39.8 million.
- Total revenue grew by $37.3 million to $232.9 million.
- Statutory net profit after tax increased by $58.6 million to $82.2 million.
- Higher average beef sales prices achieved despite lower volumes.
- Strategic investments in Better Beef program and infrastructure projects.
- Strong financial results supported by global distribution network and brand portfolio.
- Higher cattle sales volumes and prices due to strategic timing.
- Unrealised fair value gain on herd valued at $94.7 million.
- Core Free Cash Flow increased by $19.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Agricultural Company Limited (AAC) ORDINARY FULLY PAID |
Consumer Staple |
$871 |
FY26 Half Year Media Release
|
20 Nov 2025 8:17AM |
$1.440 |
$1.445 |
risen by
0.35%
|
|
AAC - Price-sensitive ASX Announcement
Full Release
Key Points
- AACo delivered a first-half operating profit of $39.8 million.
- Operating profit increased by 97% compared to the previous period.
- Revenue increased by almost 20% to $232.9 million.
- Average beef prices per kilogram increased by 7% to $18.62.
- Stable production cost was maintained at $2.46 per kilogram.
- Statutory Net Profit After Tax rose to $82.2 million.
- Strategic focus areas include Better Beef, Unlocking the Value of the Land, and Partner and Invest.
- Investments in sustainability projects were emphasized, including a landscape carbon project.
- AACo is poised for long-term growth through strategic initiatives and market positioning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Agricultural Company Limited (AAC) ORDINARY FULLY PAID |
Consumer Staple |
$871 |
FY26 Half Year Financial Report
|
20 Nov 2025 8:17AM |
$1.440 |
$1.445 |
risen by
0.35%
|
|
| Australian Agricultural Company Limited (AAC) ORDINARY FULLY PAID |
Consumer Staple |
$871 |
FY26 Half Year Results - Appendix 4D
|
20 Nov 2025 8:17AM |
$1.440 |
$1.445 |
risen by
0.35%
|
|
AAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Beef sales increased by 3% to $151.6 million.
- Cattle sales increased by 71% to $81.3 million.
- Operating profit rose by 97% to $39.8 million.
- Statutory EBITDA increased by 130% to $148.2 million.
- Statutory EBIT rose by 160% to $132.4 million.
- Statutory net profit after tax increased by 248% to $82.2 million.
- Net operating cash inflow decreased by 49% to $2.2 million.
- Total assets increased by 6% to $2,566.8 million.
- Gearing ratio slightly reduced by 0.5 percentage points to 23.4%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVZ Limited (EVZ) ORDINARY FULLY PAID |
Industrials |
$27 |
Earnings Guidance - 1H FY2026
|
20 Nov 2025 8:17AM |
$0.215 |
$0.220 |
risen by
2.33%
|
|
EVZ - Price-sensitive ASX Announcement
Full Release
Key Points
- EVZ Limited anticipates revenue between $60 million and $65 million for 1H FY2026.
- EBITDA is forecasted to be in the range of $3.7 million to $4.3 million.
- Revenue and EBITDA improvements reflect operational enhancements.
- Guidance is based on preliminary unaudited financial data.
- Final results will be announced in February 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bravura Solutions Limited (BVS) ORDINARY FULLY PAID |
Information Technology |
$1,152 |
Change of Director's Interest Notice
|
20 Nov 2025 8:17AM |
$2.370 |
$2.570 |
risen by
8.44%
|
|
| DevEx Resources Limited (DEV) ORDINARY FULLY PAID |
Materials |
$97 |
DevEx Expands Exploration Tenure in Alligator Rivers, NT
|
20 Nov 2025 8:16AM |
$0.170 |
$0.175 |
risen by
2.94%
|
|
DEV - Price-sensitive ASX Announcement
Full Release
Key Points
- DevEx acquires nine uranium exploration licences from Rio Tinto.
- The acquisition covers 7,200 square kilometres in the Alligator Rivers Uranium Province.
- The acquisition aligns with DevEx's strategy for high-grade uranium exploration.
- The agreement includes a deposit, completion payment, and a contingent payment.
- DevEx plans to integrate new exploration targets into their plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aneka Tambang (Persero) Tbk (Pt) (ATM) CHESS DEPOSITARY INTERESTS 1:5 |
Materials |
$4,086 |
Report of Material Information of Facts
|
20 Nov 2025 8:16AM |
$1.000 |
$0.850 |
fallen by
15%
|
|
| SPDR S&P/ASX 200 Fund (STW) |
Financials |
$6,162 |
Daily Fund Update
|
20 Nov 2025 8:16AM |
$76.130 |
$77.930 |
risen by
2.36%
|
|
| SPDR S&P/ASX 200 Listed Property Fund (SLF) |
Financials |
$544 |
Daily Fund Update
|
20 Nov 2025 8:16AM |
$13.450 |
$13.730 |
risen by
2.08%
|
|
| TPG Telecom Limited (TPG) ORDINARY FULLY PAID |
Communication Services |
$7,440 |
Retail Reinvestment Plan Prospectus
|
20 Nov 2025 8:15AM |
$3.730 |
$3.790 |
risen by
1.61%
|
|
TPG - Price-sensitive ASX Announcement
Full Release
Key Points
- TPG Telecom's Retail Reinvestment Plan opens on 20 November 2025 and closes on 5 December 2025.
- Eligible retail shareholders can reinvest capital return proceeds of $1.61 per share to purchase new shares.
- The minimum application amount is $500, with the potential to raise approximately $138 million.
- New share offer price is the lower of $3.61 or a 5% discount on recent average market price.
- Strategic shareholders will not participate, aiming to increase free float for public trading.
- Funds raised will be used to repay TPG Telecom's bank borrowings.
- Offer designed to enhance liquidity and support TPG's position in market indices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,272 |
Update - Notification of buy-back - DOW
|
20 Nov 2025 7:38AM |
$7.560 |
$7.950 |
risen by
5.16%
|
|
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$5,272 |
Becoming a substantial holder
|
20 Nov 2025 7:32AM |
$7.560 |
$7.950 |
risen by
5.16%
|
|
| TURNERS AUTOMOTIVE GROUP LIMITED (TRA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$643 |
Dividend/Distribution - TRA
|
20 Nov 2025 7:32AM |
$6.750 |
$7.080 |
risen by
4.89%
|
|
| TURNERS AUTOMOTIVE GROUP LIMITED (TRA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$643 |
Turners HY26 results presentation
|
20 Nov 2025 7:31AM |
$6.750 |
$7.080 |
risen by
4.89%
|
|
TRA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 5% to $219 million.
- Net profit after tax rose by 13% to $21.9 million.
- Gross written premiums grew by 10%.
- Focus on improving capital effectiveness.
- Digital platforms are enhancing insurance distribution.
- Transition from wholesale to retail driven by stock and economy.
- Challenges include sluggish retail demand and aging vehicle fleet.
- Opportunities in damaged and end-of-life vehicle segments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TURNERS AUTOMOTIVE GROUP LIMITED (TRA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$643 |
Turners Maintains Momentum -Record First Half Performance
|
20 Nov 2025 7:31AM |
$6.750 |
$7.080 |
risen by
4.89%
|
|
TRA - Price-sensitive ASX Announcement
Full Release
Key Points
- Turners Automotive Group Limited reported a record first-half performance for the six months ended 30 September 2025.
- The group operates through five segments: Auto retail, Finance, Insurance, Credit management, and Corporate & other.
- Revenue for the period was NZD 222.6 million, with a net profit attributable to shareholders of NZD 21.9 million.
- The Automotive retail segment contributed the largest revenue of NZD 155.4 million.
- The finance segment, providing loans to consumers and SMEs, generated revenue of NZD 37 million.
- Insurance revenue, covering life and consumer products, was NZD 25.6 million.
- Credit management services revenue was NZD 4.6 million.
- Turners Marque ABS 2025-1 Trust was established for a $200 million receivables purchase.
- The group paid a fully imputed dividend of NZD 0.1111 per share.
- Turners Group is listed with the ticker TRA on the New Zealand Exchange.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AFT Pharmaceuticals Limited (AFP) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$315 |
FY26 Interim presentation
|
20 Nov 2025 7:31AM |
$2.710 |
$3.000 |
risen by
10.70%
|
|
AFP - Price-sensitive ASX Announcement
Full Release
Key Points
- AFT Pharmaceuticals experienced a substantial revenue growth of 31% in Australia, reaching $66.5 million.
- The company's New Zealand revenues increased by 8%, with a focus on allergy, dermatology, and eyecare.
- AFT's international revenues doubled to $11 million due to normal buying patterns and new product launches.
- AFT Pharmaceuticals aims to achieve $300 million in annual revenue by FY27.
- Significant R&D investments are underway to sustain long-term growth and geographical diversification.
- The company plans to continue expanding its product portfolio, including Maxigesic, across various global markets.
- AFT has a strategic focus on enhancing its presence in the Asian market, with a 69% revenue increase.
- The company anticipates a strong second half of FY26, with expected greater sales and earnings.
- AFT's research and development expenses are supported by positive cashflows.
- The company has a robust inventory and is well-positioned for future growth investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AFT Pharmaceuticals Limited (AFP) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$315 |
FY26 Interim Report
|
20 Nov 2025 7:31AM |
$2.710 |
$3.000 |
risen by
10.70%
|
|
AFP - Price-sensitive ASX Announcement
Full Release
Key Points
- AFT Pharmaceuticals reported a profit after tax of $3.298 million for the six months ended 30 September 2025.
- Total revenue for this period was $114.942 million, an increase from $86.713 million in the same period the previous year.
- The company experienced net foreign exchange gains of $829k.
- Dividends paid during this period amounted to $1.888 million.
- The company reported a total comprehensive income of $3.362 million attributable to the equity holders.
- The cash flow from operating activities was reported as a net inflow of $476k.
- Total assets as of 30 September 2025 were valued at $171.622 million.
- The company's financial performance benefited from increased sales across all regions, notably in Australia and New Zealand.
- AFT Pharmaceuticals is involved in joint operations with Hyloris Pharmaceuticals for the Maxigesic IV product.
- The company maintains a strong focus on managing its liquidity and capital structure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AFT Pharmaceuticals Limited (AFP) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$315 |
FY26 Interim release
|
20 Nov 2025 7:31AM |
$2.710 |
$3.000 |
risen by
10.70%
|
|
AFP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue grew by 33% to $114.9 million.
- Strong growth observed in Australian, Asian, and International markets.
- Operating profit reached $4.7 million.
- Net profit after tax was $2.7 million.
- Continued investment in international business hubs and R&D.
- Executed multiple out-licensing agreements.
- Advanced in-licensing program to enhance product offerings.
- Anticipates stronger sales in the second half of FY26.
- Targets $300 million in revenue by FY27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Meridian Energy Limited (MEZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$12,930 |
Meridian Investor Day Presentation
|
20 Nov 2025 7:30AM |
$5.110 |
$4.900 |
fallen by
4.11%
|
|
| The a2 Milk Company Limited (A2M) ORDINARY FULLY PAID |
Consumer Staple |
$6,681 |
Annual Meeting Chair's Speech and CEO's Address
|
20 Nov 2025 7:30AM |
$9.220 |
$9.210 |
fallen by
0.11%
|
|
| The a2 Milk Company Limited (A2M) ORDINARY FULLY PAID |
Consumer Staple |
$6,681 |
2025 Annual Meeting Presentation
|
20 Nov 2025 7:30AM |
$9.220 |
$9.210 |
fallen by
0.11%
|
|
Call 1300 880 160
Start a chat
Schedule a call
